Biography

Dr Thomas Wagner is a nuclear medicine consultant who has worked at the Royal Free London since 2011.

His special interests include the role of PET-CT in haematological and respiratory malignancies and in infection/inflammation.

Languages

English

French

GMC number

7086249

• Pencharz DR, Hanlon P, Chakravartty R, Navalkissoor S, Quigley AM, Wagner T. Nucl Med Rev Cent East Eur. 2014;17(2):65-9. doi: 10.5603/NMR.2014.0019.Automated quantification with BRASS reduces equivocal reporting of DaTSCAN (123I-FP-CIT) SPECT studies.Pencharz DR1, Hanlon P, Chakravartty R, Navalkissoor S, Quigley AM, Wagner T.
• Moulis G, Sailler L, Bonneville F, Wagner T. Imaging in Erdheim-Chester disease: classic features and new insights. Clin Exp Rheumatol. 2014 May-Jun;32(3):410-4. Epub 2014 Jan 14.
• McMeekin H, Wagner T, Burniston M, McCool D.400 MBq of 18F-FDG: one size no longer fits all? McMeekin H, Wagner T, Burniston M, McCool D. Nucl Med Commun. 2014 Jul;35(7):781-2. doi: 10.1097/MNM.0000000000000115
• Cheung KK, Wagner T, Hall M, Dvorkin L Abdominopelvic Splenosis-An Unusual Cause of Tenesmus. Cheung KK, Wagner T, Hall M, Dvorkin L. J Gastrointest Surg. 2014 May 29.
• Mandegaran R, Debard A, Alvarez M, Marchou B, Massip P, Wagner T. Disseminated osteomyelitis or bone metastases of breast cancer: 18F-FDG-PET/CT helps unravel an unusual presentation. Ann Nucl Med. 2013 Nov 8.
• Sonoda LI, Wagner T, Sanghera B, Wong WL. 18F-FDG PET/CT appearances of adult pulmonary blastoma. Clin Nucl Med. 2013 Sep;38(9):737-8
• Pencharz D, Quigley AM, Hall M, Wagner TL. Rapid and severe adverse reaction to adenosine during a pharmacological stress test for a myocardial perfusion scan. Clin Nucl Med. 2013 Sep;38(9):758.
• Dziadzio M, Chee R, McNamara C, Deheragoda M, Wagner T, Seneviratne SL. EBV-driven diffuse large B-cell lymphoma confined to the liver in a patient with a history of idiopathic CD4 lymphocytopenia. BMJ Case Rep. 2013 Aug 21;2013.
• Kyrtatos PG, Debard A, Martin-Blondel G, Alvarez M, Delobel P, Marchou B, Massip P, Wagner T. FDG-PET/CT findings during immune reconstitution in an HIV-1 patient infected with visceral leishmaniasis. Infection. 2013 May 25. [Epub ahead of print]
• Kyrtatos PG, Navalkissoor S, Burniston M, Wagner T. “Planar images reprojected from SPECT V/Q data perform similarly to traditional planar V/Q scans in the diagnosis of pulmonary embolism”. Nucl Med Commun. 2013 May;34(5):445-50. doi: 10.1097/MNM.0b013e32835fa531.
• Ziai D, Wagner T, El Badaoui A, Hitzel A, Woillard JB, Melloni B, Monteil J. “Therapy response evaluation with FDG-PET/CT in small cell lung cancer: a prognostic and comparison study of the PERCIST and EORTC criteria”. Cancer Imaging. 2013 Mar 5;13:73-80. doi: 10.1102/1470-7330.2013.0008.
• Wagner T, Gnanasegaran G, Buscombe J, Navalkissoor S. “SPECT/CT in sentinel lymph node”. Nucl Med Commun. 2013 Mar;34(3):191-202. doi: 10.1097/MNM.0b013e32835c5a24.
• Wagner T, Brechemier D, Dugert E, Le Guellec S, Julian A, Hitzel A, Beyne-Rauzy O. “Diffuse pulmonary uptake on FDG PET with normal CT diagnosed as intravascular large B-cell lymphoma: a case report and a discussion of the causes of diffuse FDG uptake in the lungs” (2011) Cancer imaging, 2012 Jan 23;12(1):7-12.
• Wagner T, Brucher N, Julian A, Hitzel A “False-positive finding in therapeutic evaluation: appearance of a hypermetabolic axillary lymph node in a lymphoma patient following FDG extravasation” Nucl Med Rev Cent East Eur. 2011;14(2):109-11.
• Wagner T, Chevreau C, Meyer N, Mourey L, Courbon F, Zerdoud S. “Routine FDG PET-CT in patients with a high-risk localized melanoma has a high predictive positive value for nodal disease and high negative predictive value for the presence of distant metastases”. J Eur Acad Dermatol Venereol. 2012 Nov;26(11):1431-5.
• Wagner T, Meyer N, Zerdoud S, Julian A, Chevreau C, Payoux P, Courbon F “FDG PET fails to detect distant metastases at initial staging in melanoma patients with metastatic involvement of sentinel lymph node”. British Journal of Dermatology 2011 Jun;164(6):1235-4
• Julian A, Wagner T, Ysebaert L, Chabbert V, Payoux P “FDG-PET/CT is useful in detecting unknown metastatic involvement of the heart in Non Hodgkin’s lymphoma”. European Journal of Nuclear Medicine and Molecular Imaging. 2011 Jun;38(6):1174
• Bui E, Delrieu J, Wagner T, Rieu J, Véry E, Payoux P, Schmitt L Iodine-123 Fluoropropyl-Carbomethoxy-3-ß-(4-Iodophenyltropane) single-photon emission computed tomography findings before and after electroconvulsive therapy in major depressive disorder with Parkinsonism. Journal of Electroconvulsive Therapy, 2011 Dec;27(4):331-3..
• Julian A, Wagner T, Payoux P, Hitzel A, Esquerré JP. “Assessment of therapy response in lymphoma: role of FDG-PET”. MédecineNucléaire 35 (2011) 21–28.
• Wagner T, Payoux P, Simon J, Tafani M, Esquerre JP, Bonnet E “ Discordance between labelled white blood cell scintigraphy and bone scan following suspicion of bone infection: What should be done about it?”. (2010) Nuclear Medicine Review Vol. 13, No. 1, pp. 5–7